---
title: "Cassava Sciences says US DOJ has closed investigation into company"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/276340700.md"
description: "Feb 19 (Reuters) - Cassava Sciencessaid on Thursday the U.S. Department of Justice had ended its probe into the company regarding allegations of research misconduct for its experimental Alzheimer’s drug simufilam.The company said the probe ended four months after the Justice Department dismissed a criminal indictment in Maryland accusing Hoau-Yan Wang, a medical professor and former Cassava adviser who allegedly submitted false data regarding the drug."
datetime: "2026-02-19T13:47:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276340700.md)
  - [en](https://longbridge.com/en/news/276340700.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276340700.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/276340700.md) | [繁體中文](https://longbridge.com/zh-HK/news/276340700.md)


# Cassava Sciences says US DOJ has closed investigation into company

Feb 19 (Reuters) - Cassava Sciences (SAVA.O) said on Thursday the U.S. Department of Justice had ended its probe into the company regarding allegations of research misconduct for its experimental Alzheimer’s drug simufilam.

The company said the probe ended four months after the Justice Department dismissed a criminal indictment in Maryland accusing Hoau-Yan Wang, a medical professor and former Cassava adviser who allegedly submitted false data regarding the drug.

### 相关股票

- [iShares US Pharma (IHE.US)](https://longbridge.com/zh-CN/quote/IHE.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [iShares Global Healthcare (IXJ.US)](https://longbridge.com/zh-CN/quote/IXJ.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-CN/quote/FBT.US.md)
- [Cassava Sciences (SAVA.US)](https://longbridge.com/zh-CN/quote/SAVA.US.md)
- [VG Health (VHT.US)](https://longbridge.com/zh-CN/quote/VHT.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-CN/quote/XLV.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-CN/quote/XBI.US.md)
- [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-CN/quote/ARKG.US.md)
- [FILANA THERAPEUTICS INC (FLNA.US)](https://longbridge.com/zh-CN/quote/FLNA.US.md)

## 相关资讯与研究

- [Filana leaves Cassava roots behind amid branch into epilepsy](https://longbridge.com/zh-CN/news/278579055.md)
- [AbbVie's ABBV-295 Shows Strong Weight Loss Results in Phase 1 Trial](https://longbridge.com/zh-CN/news/278398258.md)
- [Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study](https://longbridge.com/zh-CN/news/278381816.md)
- [Vanda Advances NEREUS Launch With Direct-to-Consumer Strategy](https://longbridge.com/zh-CN/news/278644625.md)
- [AbbVie reports topline data from Phase I ABBV-295 trial](https://longbridge.com/zh-CN/news/278540526.md)